Antiplatelet therapy for secondary prevention of the complications of atherothrombotic disease.

Objective: To review and summarize key studies of secondary prevention of atherothrombotic events.

Data Sources: English language clinical trials and guidelines.

Study Selection: Key clinical trials and guidelines were selected by the authors based on their perceived importance and relevance to consultant pharmacists.

Data Extraction: The authors reviewed and summarized clinical trials and guidelines published in the English literature.

Data Synthesis: Each clinical trial and guideline was summarized by the authors.

Conclusion: Key clinical trials and guidelines regarding the secondary prevention of atherothrombotic events have great significance to consultant pharmacy.